As of 2026-04-06, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 17.4x | 14.5x |
| Forward P/E multiples | 17.1x - 21.4x | 19.7x |
| Fair Price | (210.74) - (214.53) | (211.21) |
| Upside | -4340.2% - -4416.6% | -4349.7% |
| Date | EV/EBITDA |